About 1600 kidney transplants are performed each year in France. The qualit
y of life of grafted patients has therefore improved, to the extent that su
ch patients are now envisaging professional or other activity and stays in
tropical or sub-tropical regions. However, this is not without some degree
of risk or difficulty.
Anti-malarial drugs may interfere with other medication, particularly ciclo
sporin in kidney grafted patients. Moreover, other vaccinations such as ant
i-amaril immunization are recommanded or even required by certain countries
. Yet the immunodepression induced by this in grafted patients is a contrai
ndication for such vaccination. For the other types of immunization, the ri
sk/benefit ratio is not always obvious.